According to Mirati Therapeutics's latest financial reports the company's current revenue (TTM) is £29.1 M. In 2022 the company made a revenue of £10.27 M a decrease over the revenue in the year 2021 that were of £53.26 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.